Trial Profile
Growth Response in Girls With Turner Syndrome During a Three-year GH Treatment Comparing Two Dose Regimens. Identification of Predictive Factors of Growth Response
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Mar 2017
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Growth disorders
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 30 Apr 2015 New trial record